351 related articles for article (PubMed ID: 24647663)
1. Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.
Zhang C; Zhang X; Chen XH
Clin Rev Allergy Immunol; 2014 Oct; 47(2):163-73. PubMed ID: 24647663
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching P; Stradner M; Graninger W; Dejaco C; Fessler J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098832
[TBL] [Abstract][Full Text] [Related]
3. Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.
Kosmaczewska A
Int J Mol Sci; 2014 Oct; 15(10):18574-92. PubMed ID: 25322151
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of the interleukin-6 receptor.
Tanaka T; Narazaki M; Kishimoto T
Annu Rev Pharmacol Toxicol; 2012; 52():199-219. PubMed ID: 21910626
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
[TBL] [Abstract][Full Text] [Related]
9. Generation of RORγt
Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.
Hayes ET; Hagan CE; Khoryati L; Gavin MA; Campbell DJ
J Immunol; 2020 Nov; 205(10):2667-2678. PubMed ID: 33055282
[TBL] [Abstract][Full Text] [Related]
11. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells.
Lee JH; Ulrich B; Cho J; Park J; Kim CH
J Immunol; 2011 Aug; 187(4):1778-87. PubMed ID: 21768398
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.
Jones SA; Scheller J; Rose-John S
J Clin Invest; 2011 Sep; 121(9):3375-83. PubMed ID: 21881215
[TBL] [Abstract][Full Text] [Related]
13. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
15. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody.
Mihara M; Ohsugi Y; Kishimoto T
Biofactors; 2009; 35(1):47-51. PubMed ID: 19319845
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
Schinnerling K; Aguillón JC; Catalán D; Soto L
Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo.
Glauben R; Sonnenberg E; Wetzel M; Mascagni P; Siegmund B
J Biol Chem; 2014 Feb; 289(9):6142-51. PubMed ID: 24421314
[TBL] [Abstract][Full Text] [Related]
19. DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway.
Yin X; Wei H; Wu S; Wang Z; Liu B; Guo L; Bi H; Guo D
Int Immunopharmacol; 2020 Feb; 79():106107. PubMed ID: 31863921
[TBL] [Abstract][Full Text] [Related]
20. Anticytokine therapy in autoimmune diseases.
Nishimoto N; Kishimoto T; Yoshizaki K
Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
